首页> 外文期刊>Macromolecular bioscience >Two-Component In situ Forming Supramolecular Hydrogels as Advanced Biomaterials in Vitreous Body Surgery
【24h】

Two-Component In situ Forming Supramolecular Hydrogels as Advanced Biomaterials in Vitreous Body Surgery

机译:两组分原位形成超分子水凝胶作为玻璃体手术中的先进生物材料

获取原文
获取原文并翻译 | 示例
           

摘要

Polymeric β-CD and poly{(2-acrylamido-2-methyl-1-propanesulfonic acid sodium salt)-co-[6-(acrylamido)-N-adamantylhexaneamide]} are synthesized to build in situ forming hydrogels based on host/guest interactions, so called physical hydrogels. The use of these hydrogels as a potential vitreous body substitute is discussed and recommended. Potential changes in cell morphology and cell vitality of the retinal ganglion cell line RGC-5 are determined. DSC experiments with artificial membrane structures are performed. The analyses show that β-CD overrides the harmful effects of the highly toxic adamantyl-modified polymer. Although the final hydrogel is considered to be biocompatible, the application as a biomaterial has to be reconsidered.
机译:合成聚合物β-CD和聚{(2-丙烯酰胺基-2-甲基-1-丙磺酸钠盐)-co- [6-(丙烯酰胺基)-N-金刚烷基己酰胺]}共聚体,以基于宿主/的方式原位形成水凝胶客体相互作用,即所谓的物理水凝胶。讨论并推荐了将这些水凝胶用作潜在的玻璃体替代物。确定视网膜神经节细胞系RGC-5的细胞形态和细胞活力的潜在变化。用人造膜结构进行DSC实验。分析表明,β-CD取代了高毒性金刚烷基改性聚合物的有害作用。尽管最终的水凝胶被认为具有生物相容性,但必须重新考虑其作为生物材料的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号